Official Title
Clinical Presentation and Incidence of SARS-CoV-2 Infection in Different Cohorts of Solid Organ Transplant Patients and Follow-up in France
Brief Summary

Patients with comorbid condition are known to be at high risk of severe forms of Covid-19. It is highly probable that immunocompromised patients like solid organ transplant (SOT) recipients are also at risk of severe forms of Covid-19. For this purpose, The investigators conducted a nationwide multicentric and multiorgan Registry to collect data about all French SOT recipients who develop a SARS-CoV-2 infection. The aim is to describe the clinical, biological and virological characteristics of these patients and to give information about evolution and prognosis of these particular population

Unknown status
SARS-CoV-2
Eligibility Criteria

Inclusion Criteria:

- All Solid Organ Transplant recipients with a functioning graft and a high suspicion or
a confirmed SARS-CoV-2 infection

- Adult and pediatric

Exclusion Criteria:

- There are no exclusion criteria, except for the patient's explicit refusal to participate

Eligibility Gender
All
Eligibility Age
Minimum: 1 Year ~ Maximum: N/A
Countries
France
Locations

Service de Néphrologie et Transplantation
Strasbourg, France

Investigator: Sophie CAILLARD, MD, PhD
Contact: 33 3 69 55 13 20
sophie.caillard@chru-strasbourg.fr

Investigator:

Contacts

Sophie CAILLARD, MD, PhD
33 3 69 55 13 20
sophie.caillard@chru-strasbourg.fr

Saïd CHAYER, PhD, HDR
33 3 88 11 66 90
said.chayer@chru-strasbourg.fr

Sophie CAILLARD, MD, PhD, Study Director
Service de Néphrologie et Transplantation

University Hospital, Strasbourg, France
NCT Number
Keywords
SARS-CoV-2
Covid-19
Solid Organ transplantation
Incidence
Prognosis
Cellular response
Humoral Response